Comerica Bank Biotechnology

Comerica Bank

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
EYPT Eye Point Pharmaceuticals, Inc.	$336M	$0 0.0% of portfolio	98	Q1 2025 Reduced 74.01%
LXRX Lexicon Pharmaceuticals, Inc.	$166M	$0 0.0% of portfolio	122	Q4 2024 New
LYRA Lyra Therapeutics, Inc.	$290M	$0 0.0% of portfolio	1,159	Q3 2023 New
MGNX Macrogenics Inc	$86M	$0 0.0% of portfolio	44	Q4 2024 New
PLRX Pliant Therapeutics, Inc.	$58.9M	$0 0.0% of portfolio	14	Q1 2025 Reduced 84.62%
SAGE Sage Therapeutics, Inc.	$547M	$0 0.0% of portfolio	120	Q4 2024 Added 1,400.0%
SRRK Scholar Rock Holding Corp	$1.74B	$0 0.0% of portfolio	9	Q1 2025 New
SMMT Summit Therapeutics Inc.	$4.61B	$0 0.0% of portfolio	22	Q4 2024 New
STRO Sutro Biopharma, Inc.	$39.1M	$0 0.0% of portfolio	49	Q1 2024 Reduced 73.8%
VERA Vera Therapeutics, Inc.	$619M	$0 0.0% of portfolio	11	Q1 2025 New
VRDN Viridian Therapeutics, Inc.\De	$637M	$0 0.0% of portfolio	65	Q3 2024 Added 8.33%

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.